CTD402, an allogeneic CAR T-cell therapy, is designed for immediate administration and targets relapsed/refractory T-ALL and ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

This year, we bring you Mikie’s World, a weekly newsletter about the freshly minted administration of Gov. Mikie Sherrill, the Democratic former congresswoman and Navy helicopter pilot who won that ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that the U.S. Food and Drug Administration has granted orphan drug ...

Hydrogen powertrain developer ZeroAvia has finally broken its silence on the sweeping redundancies made by the company in recent weeks that have seen around half of its workforce culled on the back of ...

FDA approved Novo Nordisk’s oral Wegovy pill for obesity and cardiovascular risk reduction, followed by a successful U.S. launch. The company announced plans to reduce its workforce by 9,000 roles as ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

Union Budget 2026 is set for February 1. Experts expect focus on jobs, agriculture, MSMEs, green energy, EVs, healthcare, ...

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best strong buy stocks to invest in under $5. AbCellera Biologics Inc.

Sanofi’s Rezurock Receives Positive CHMP Recommendation, Advancing New Treatment Option for Chronic GVHD in Europe ...

OMEICOS, a clinical-stage biopharmaceutical company developing first-in-class small molecule therapeutics for mitochondrial and inflammatory disorders, announced the successful conclusion of its multi ...